Large Granular Lymphoproliferative Disease Associated with Nephrotic Syndrome, Renal Failure and Leukoencephalopathy

References

• Lanier L. L., Phillips J. H., Hackett J., Jr., Tutt M. Natural killer cells: definition of a cell type rather than a function. J. Immunol. 1986; 137: 2735–52739
   PubMed Web of Science ®Google Scholar
• Berliner N. T gamma lymphocytosis and T-cell chronic leukemias. Hemutol. Oncol. Clinics N. Am. 1990; 4: 473–487
   PubMed Web of Science ®Google Scholar
• Pandolfi F., Loughran T. P., Jr., Starkebaum G., et al. Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study. Cancer 1990; 65: 341–348
   PubMed Web of Science ®Google Scholar
• Catovsky D., Foa R. T-cell chronic lymphocytic leukaemia/T-cell lymphocytosis. The Lymphoid Leukaemias. Butterworth, London 1990; 113–131
   Google Scholar
• Scott C. S. Human NK cells in health and disease: clinical, functional, phenotypic and DNA genotypic characteristics. Leuk. Lymph. 1992, in press
   PubMed Web of Science ®Google Scholar
• Pross H. F., Baines M. G., Rubin P., Shragge P., Patterson M. S. Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. 1X. The quan-titation of natural killer cell activity. J. Clin. Immunol. 1981; 1: 51–5s
   PubMed Web of Science ®Google Scholar
• Pross H. F., Maroun J. A. The standardization of NK cell assays for use in studies of biological response modifiers. J. Iminunol. Merho 1984; 68: 235–249
   Google Scholar
• Imamura N., Kusonoki Y., Kawa-Ha K., Yumura K., Hara J. Aggressive natural killer cell leukaemia/lym-phoma: report of 4 cases and review of the literature. Br. J. Haemutol. 1990; 75: 49–59
   PubMed Web of Science ®Google Scholar
• Langs C., Gallo G. R., Schacht R. G., Sidhu G., Baldwin D. S. Rapid renal failure in AIDS-associated focal glomerulosclerosis. Arch. Inter. Mrd. 1992; 150: 287–292
   Web of Science ®Google Scholar
• Carbone L., D'Agati V., Cheng J. T., Appel G. B. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am. J. Med. 1989; 87: 389–395
   PubMed Web of Science ®Google Scholar
• Cunningham E. E., Brentjens J. R., Zielezny M. A., Andres G. A., Venuto R. C. Heroin nephropathy. A din-icopathologic and epidemiologic study. Am. J. Med. 1980; 68: 47–53
   PubMed Web of Science ®Google Scholar
• Cunningham E. E., Zielezny M. A., Venuto R. C. Heroin-associated nephropathy. A nationwide problem. JAMA 1983; 250: 2935–2936
   PubMed Web of Science ®Google Scholar
• Friedman E. A., Roa T. K. S. Why does uremia in heroin abusers occur predominantly among Blacks?. JAMA 1983; 250: 2965–2966
   PubMed Web of Science ®Google Scholar
• Orman S. V., Schechter G. P., Whang-Peng J., et al. Nephrotic syndrome associated with a clonal T-cell leukemia of large granular lymphocytes with cytotoxic function. Arch. Inter. Med. 1986; 146: 1827–1829
   PubMed Web of Science ®Google Scholar
• Bassan R., Rambaldi A., Abbate M., et al. Association of NK-cell lymphoproliferative disease and nephrotic syndrome. Am. J. Clin Purhol. 1990; 94: 334–338
   PubMed Web of Science ®Google Scholar
• Shalhoub R. J. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974; 2: 556–560
   PubMed Web of Science ®Google Scholar
• Fillit H. M., Zabriskie J. B. Cellular immunity in glomerulonephritis. Am. J. Parhol. 1982; 109: 227–243
   Web of Science ®Google Scholar
• Koyama A., Fujisaki M., Kobayashi M., Igarishi M., Naritaa M. A glomerular permeability factor produced by human T-cell hybridomas. Kidney Inr. 1991; 40: 453–460
   PubMed Web of Science ®Google Scholar
• Kasahara T., Djeu J. Y., Dougherty S. F., Oppenheim J. J. Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2 inter-feron, and colony stimulating factor. J. Immunol. 1983; 131: 2379–2385
   PubMed Web of Science ®Google Scholar
• Procopio A. D., Allavena P., Ortaldo J. R. Non-cytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF). J. Immunol. 1985; 135: 3264–3269
   PubMed Web of Science ®Google Scholar
• Perussia B. Lymphokine-activated killer cells, natural killer cells and cytokines. Current Opinion in Immunol. 1991; 3: 49–55
   PubMed Web of Science ®Google Scholar
• Hoffman P. M., Fleming J. O. Neurovirology. Neurology in Clinical Practice: Principles of Diagnosis and Management, W. G. Bradley, R. B. Daroff, G. M. Fenichel, C. D. Marsden. Butter-worth-Heineman, Boston 1991; 595–609
   Google Scholar
• Sriram S., Steinman L. Postinfectious and post-vaccinia1 encephalomyelitis. Neurol. Clinics 1984; 2: 341–353
   PubMed Web of Science ®Google Scholar
• Francis G. S., Antel J. P., Duguette P. Inflammatory demyelinating diseases of the central nervous system. Neurology in Clinical Practice: Principles of Diagnosis and Management, W. G. Bradley, R. B. Daroff, G. M. Fenichel, C. D. Marsden. But-terworth-Heineman, Boston 1991; 1134–1166
   Google Scholar
• Thajeb P., Chen S. T. Cranial computed tomography in acute disseminated encephalomyelitis. Neuroradiol-ogy 1989; 31: 8–12
   PubMed Web of Science ®Google Scholar
• Epperson L. W., Whitaker J. N., Kapila A. Cranial MRI in acute disseminated encephalomyelitis. Neurology 1988; 38: 332–333
   PubMed Web of Science ®Google Scholar
• Kesselring J., Miller D. H., Kobb S. A., et al. Acute disseminated encephalomyelitis. MRI findings and the distinction from multiple sclerosis. Brain 1990; 113: 291–302
   PubMed Web of Science ®Google Scholar
• Johnson R. T., Griffin D. E., Gendelman H. E. Postinfectious encephalomyelitis. Seminars in Neurol. 1985; 5: 180–190
   Web of Science ®Google Scholar
• Wisniewski H. M., Bloom B. R. Primary de-myelination as a nonspecific consequence of a cell-mediated immune reaction. J. Exp. Med. 1975; 141: 346–359
   PubMed Web of Science ®Google Scholar
• Stoner G. L., Brosnan C. F., Wisniewski H. M., Bloom B. K. Studies on demyelination by activated lymphocytes in the rabbit eye. I. Effects of a mononuclear cell infiltrate induced by products of activated lymphocytes. J. Immunol. 1977; 118: 2094–2102
   PubMed Web of Science ®Google Scholar
• Powell M. B., Mitchell D., Lederman J., et al. Lym-photoxin and tumor necrosis factor-alpha production by mye-lin basic protein-specific T-cell clone correlates with encepha-litogenicity. Int. Immunol. 1992; 2: 539–544
   Web of Science ®Google Scholar
• Tyor W. R., Glass J. D., Griffin J. W., et al. Cy-tokine expression in the brain during the acquired immunodeficiency syndrome. Ann. Neurol. 1992; 31: 349–360
   PubMed Web of Science ®Google Scholar
• Galili U. Glucocorticoid-induced lysis of human leukemia cells. frog. Clin. Biolog. Res. 1992; 276: 43–59
   Google Scholar
• Adams F., Quesada J. R., Gutterman J. U. Neu-ropsychiatric manifestations of human leukocyte interferon therapy in patients with cancer. JAMA 1984; 252: 938–941
   PubMed Web of Science ®Google Scholar
• Denicoff K. D., Kubinow D. R., Papa M. Z., et al. The neuropsychiatric effects of treatment with interleukin-2 and lymphokine-activated killer cells. Ann. Inter. Med. 1987; 107: 293–300
   PubMed Web of Science ®Google Scholar
• Vecht C. J., Keohane C., Menon R. S., Punt C. J., Stoter G. Acute fatal leukoencephalopathy after interleukin-2 therapy [letter]. N. Engl. J. Med. 1990; 323: 1146–1147
   PubMed Web of Science ®Google Scholar